Sun Pharma gets USFDA approval for Tildrakizumab BLA
Source: IRIS | 24 May, 2017, 11.20AM
|
|
|
|
Rating: NAN / 5 stars. |
Comments | Post Comment |
|
According to Abhay Gandhi, CEO - North America Business, Sun Pharma, ''At Sun Dermatology, we are committed to making a difference in the lives of patients and healthcare providers. The acceptance of the regulatory filing by the U.S. FDA marks a significant milestone as we seek to advance for tildrakizumab as a potential new treatment option for people who continue to struggle everyday with the chronic nature of psoriasis.''
|
|
|
|
|
|
|
|
|
|
|
|